Literature DB >> 2544855

Mutant analysis of protein interactions with a nuclear factor I binding site in the SL3-3 virus enhancer.

P Nilsson1, B Hallberg, A Thornell, T Grundström.   

Abstract

Nuclear factor I (NFI) is shown to be of importance for the activity of the enhancer element of a T-cell leukemogenic murine retrovirus, SL3-3, and for the regulation of this element by glucocorticoid. Each nucleotide of the binding site of the NFI proteins was mutated, and the effects of the mutations were quantitated with an electrophoretic mobility shift assay. Mutations in the inverted repeat of the binding site have symmetric effects which strongly support the notion that NFI proteins preferentially bind to dyad symmetry sites. Such binding sites were shown to be more than 100 fold stronger than the corresponding single binding sites. We find dyad symmetry sequences which are much stronger NFI binding sites than NFI sites identified in different genes and also stronger than previously proposed consensus binding sequences for NFI.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2544855      PMCID: PMC317919          DOI: 10.1093/nar/17.11.4061

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  54 in total

1.  Site-specific DNA binding of nuclear factor I: effect of the spacer region.

Authors:  R M Gronostajski
Journal:  Nucleic Acids Res       Date:  1987-07-24       Impact factor: 16.971

Review 2.  Regulation of inducible and tissue-specific gene expression.

Authors:  T Maniatis; S Goodbourn; J A Fischer
Journal:  Science       Date:  1987-06-05       Impact factor: 47.728

3.  The interplay of DNA-binding proteins on the promoter of the mouse albumin gene.

Authors:  S Lichtsteiner; J Wuarin; U Schibler
Journal:  Cell       Date:  1987-12-24       Impact factor: 41.582

4.  Six distinct nuclear factors interact with the 75-base-pair repeat of the Moloney murine leukemia virus enhancer.

Authors:  N A Speck; D Baltimore
Journal:  Mol Cell Biol       Date:  1987-03       Impact factor: 4.272

5.  Conserved major histocompatibility complex class II boxes--X and Y--are transcriptional control elements and specifically bind nuclear proteins.

Authors:  A Dorn; B Durand; C Marfing; M Le Meur; C Benoist; D Mathis
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

6.  A cellular DNA-binding protein that activates eukaryotic transcription and DNA replication.

Authors:  K A Jones; J T Kadonaga; P J Rosenfeld; T J Kelly; R Tjian
Journal:  Cell       Date:  1987-01-16       Impact factor: 41.582

7.  Steroid-dependent interaction of transcription factors with the inducible promoter of mouse mammary tumor virus in vivo.

Authors:  M G Cordingley; A T Riegel; G L Hager
Journal:  Cell       Date:  1987-01-30       Impact factor: 41.582

8.  Chicken liver TGGCA protein purified by preparative mobility shift electrophoresis (PMSE) shows a 36.8 to 29.8 kd microheterogeneity.

Authors:  R A Rupp; A E Sippel
Journal:  Nucleic Acids Res       Date:  1987-12-10       Impact factor: 16.971

9.  Discrete elements within the SV40 enhancer region display different cell-specific enhancer activities.

Authors:  B Ondek; A Shepard; W Herr
Journal:  EMBO J       Date:  1987-04       Impact factor: 11.598

10.  Contactpoint analysis of the HeLa nuclear factor I recognition site reveals symmetrical binding at one side of the DNA helix.

Authors:  E de Vries; W van Driel; S J van den Heuvel; P C van der Vliet
Journal:  EMBO J       Date:  1987-01       Impact factor: 11.598

View more
  21 in total

1.  Contributions to transcriptional activity and to viral leukemogenicity made by sequences within and downstream of the MCF13 murine leukemia virus enhancer.

Authors:  J C Tupper; H Chen; E F Hays; G C Bristol; F K Yoshimura
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

2.  Increased induction of osteopetrosis, but unaltered lymphomagenicity, by murine leukemia virus SL3-3 after mutation of a nuclear factor 1 site in the enhancer.

Authors:  S Ethelberg; B D Tzschaschel; A Luz; S J Diaz-Cano; F S Pedersen; J Schmidt
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

3.  Helix-loop-helix transcriptional activators bind to a sequence in glucocorticoid response elements of retrovirus enhancers.

Authors:  B Corneliussen; A Thornell; B Hallberg; T Grundström
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

4.  SL3-3 enhancer factor 1 transcriptional activators are required for tumor formation by SL3-3 murine leukemia virus.

Authors:  B Hallberg; J Schmidt; A Luz; F S Pedersen; T Grundström
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

5.  Increased lymphomagenicity and restored disease specificity of AML1 site (core) mutant SL3-3 murine leukemia virus by a second-site enhancer variant evolved in vivo.

Authors:  S Ethelberg; J Lovmand; J Schmidt; A Luz; F S Pedersen
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

6.  Analysis of the significance of two single-base-pair differences in the SL3-3 and Akv virus long terminal repeats.

Authors:  H L Morrison; H Y Dai; F S Pedersen; J Lenz
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

7.  Control of pathogenicity and disease specificity of a T-lymphomagenic gammaretrovirus by E-box motifs but not by an overlapping glucocorticoid response element.

Authors:  Ditte Ejegod; Karina Dalsgaard Sørensen; Ilona Mossbrugger; Leticia Quintanilla-Martinez; Jörg Schmidt; Finn Skou Pedersen
Journal:  J Virol       Date:  2008-10-22       Impact factor: 5.103

8.  Pathogenic determinants in the U3 region of recombinant murine leukemia viruses isolated from CWD and HRS/J mice.

Authors:  S C Lawrenz-Smith; A C Massey; D J Innes; C Y Thomas
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

9.  Origins of enhancer sequences of recombinant murine leukemia viruses from spontaneous B- and T-cell lymphomas of CWD mice.

Authors:  A C Massey; S C Lawrenz-Smith; D J Innes; C Y Thomas
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

10.  Nuclear factor 1 activates the feline leukemia virus long terminal repeat but is posttranscriptionally down-regulated in leukemia cell lines.

Authors:  M Plumb; R Fulton; L Breimer; M Stewart; K Willison; J C Neil
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.